Icon Plc (NASDAQ:ICLR) Receives $148.80 Consensus PT from Analysts

Shares of Icon Plc (NASDAQ:ICLR) have earned a consensus recommendation of “Hold” from the seventeen brokerages that are presently covering the company, Marketbeat.com reports. Three equities research analysts have rated the stock with a sell rating, seven have given a hold rating and seven have issued a buy rating on the company. The average 12-month target price among analysts that have updated their coverage on the stock in the last year is $148.80.

Several brokerages have recently weighed in on ICLR. Zacks Research lowered Icon from a “hold” rating to a “strong sell” rating in a research report on Wednesday, February 25th. Truist Financial reissued a “hold” rating and issued a $222.00 price target (down from $231.00) on shares of Icon in a research report on Thursday, January 8th. Citigroup decreased their price objective on shares of Icon from $200.00 to $120.00 and set a “neutral” rating for the company in a research note on Wednesday, March 11th. Robert W. Baird set a $119.00 target price on Icon in a research report on Friday, February 13th. Finally, Rothschild & Co Redburn set a $100.00 target price on Icon and gave the company a “neutral” rating in a research report on Tuesday, February 17th.

Hedge Funds Weigh In On Icon

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Private Trust Co. NA increased its position in Icon by 200.0% during the 3rd quarter. Private Trust Co. NA now owns 141 shares of the medical research company’s stock worth $25,000 after purchasing an additional 94 shares in the last quarter. Toth Financial Advisory Corp purchased a new position in Icon in the 4th quarter valued at about $27,000. EFG International AG acquired a new stake in shares of Icon during the 4th quarter worth about $27,000. Ameriflex Group Inc. purchased a new stake in Icon in the 3rd quarter worth approximately $33,000. Finally, Abound Financial LLC acquired a new position in Icon in the 4th quarter valued at $54,000. 95.61% of the stock is owned by institutional investors and hedge funds.

Icon Trading Down 3.9%

NASDAQ ICLR opened at $102.17 on Wednesday. Icon has a 52 week low of $66.57 and a 52 week high of $211.00. The firm has a 50 day moving average of $105.73 and a two-hundred day moving average of $151.33. The company has a quick ratio of 1.06, a current ratio of 1.06 and a debt-to-equity ratio of 0.31. The stock has a market capitalization of $8.25 billion, a PE ratio of 13.83, a price-to-earnings-growth ratio of 2.69 and a beta of 1.28.

About Icon

Icon plc (NASDAQ: ICLR) is a global provider of outsourced drug development and clinical research services to the pharmaceutical, biotechnology and medical device industries. The company partners with clients at all stages of the product life cycle, offering expertise in protocol design, trial execution and regulatory compliance across a broad range of therapeutic areas.

Icon’s service portfolio encompasses clinical trial management, data management and biostatistics, medical imaging, pharmacovigilance and safety monitoring, laboratory sciences and specialized analytical solutions.